TABLE II.
Waits for pre-defined intervals for patients with invasive breast carcinoma before and after initiation of the Rapid Diagnostic Unit (RDU)
| Wait ID | Interval | Wait time (days) | p Value | |
|---|---|---|---|---|
|
| ||||
| Mean | SD | |||
| 1 | Referral to consultationa | |||
| Before RDU | 8.2 | 7.5 | 0.051 | |
| After RDU | 9.9 | 8.0 | ||
| 2 | Consultation to diagnosis | |||
| Before RDU | 16.7 | 17.8 | 0.0001 | |
| After RDU | 2.1 | 1.84 | ||
| 3 | Diagnosis to IHCb | |||
| Before RDU | 34.2 | 27.3 | 0.001 | |
| After RDU | 7.9 | 17.5 | ||
| 4 | IHC to management | |||
| Before RDU | 32.8 | 34.5 | 0.3562 | |
| After RDU | 36.8 | 29.0 | ||
| 5 | Overall referral to management | |||
| Before RDU | 50.1 | 33.4 | 0.3806 | |
| After RDU | 53.1 | 29.5 | ||
a
“Consultation” refers to patient visit 1 within the RDU schema (after RDU) or the first physician consultation (before RDU).
b
Calculated only for patients with IHC available before management start.
SD = standard deviation; IHC = immunohistochemistry.